LEIDEN, The Netherlands, April 5, 2023 /PRNewswire/ — Pharming Group N.V. (“Pharming” or “the Company”) ( Euronext: PHARM / Nasdaq: PHAR) announces the filing of its Annual Report for the year ended December 31, 2022 (the “Period”). The Annual Report is available under the Financial…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.